Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.

BMC cancer - 23 Aug 2016

Wang Kewei, Wu Guosheng, Li Jinping, Song Wentao

Abstract excerpt

BACKGROUND: Vitamin D receptor (VDR) gene polymorphisms affect the risk of prostate cancer. However, studies investigating the relationship between VDR gene polymorphisms (Cdx2 and ApaI) and prostate cancer risk are equivocal. Therefore, we conducted a meta-analysis of all the studies to review the evidence available. METHODS: A comprehensive search of PubMed, EMBASE, and ISI Web of Science for studies published...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Deoxyribonucleases, Type II Site-Specific
Share to VDR gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Polymorphism, Genetic

Share to Prognosis

Share to Prostatic Neoplasms

Share to Receptors, Calcitriol

Source

Open in PubMed Open full text

Identifiers

PMID: 27553621
DOI: 10.1186/s12885-016-2722-2
PMCID: PMC4995777

Genes

VDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.PMID 27553621Read ↗

XPD Asp312Asn polymorphism is a risk factor for prostate cancer.Semantic proximity Read ↗

Genetic polymorphisms of vitamin D receptor and the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.Semantic proximity Read ↗

Association of Vitamin D Receptor Cdx-2 Polymorphism With Cancer Risk: A Meta-Analysis.Semantic proximity Read ↗

Association of VDR polymorphisms ( Taq I and Bsm I) with prostate cancer: a new meta-analysis.Semantic proximity Read ↗

Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.Semantic proximity Read ↗

Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer.Semantic proximity Read ↗

The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis.Semantic proximity Read ↗

Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.Semantic proximity Read ↗

Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.